102
Participants
Start Date
August 23, 2021
Primary Completion Date
September 23, 2021
Study Completion Date
June 23, 2023
Budesonide Formoterol Drug Combination
This combination will be used to treat the asthma exacerbation, patients will take one inhalation of budesonide/formoterol Turbuhaler® 100/6 μg every 5 minutes (Maximum 12 inhalations).
nebulisation of terbutaline
Patients will receive 0.1 mg/kg nebulized terbutaline 5 mg/2 ml of Terbutaline dilution diluted with 2 ml normal saline delivered by an air compressor nebuliser driven by oxygen at a flow rate of 8l/min. The duration of one dose will be approximately 20 minutes and a total of 3 doses will be administered.
CHI Créteil, Créteil
CHU Bicêtre, Le Kremlin-Bicêtre
CHU Ambroise Paré, Boulogne-Billancourt
CHU Antoine Béclère, Clamart
Centre Hospitalier Sud Francilien, Corbeil-Essonnes
Grand Hôpital de l'Est Francilien, Jossigny
CHU Lille, Lille
CHI Villeneuve-Saint-Georges, Villeneuve-Saint-Georges
Collaborators (1)
AstraZeneca
INDUSTRY
Centre Hospitalier Intercommunal Creteil
OTHER